NOW APPROVED!
Zimeta™ (dipyrone injection) is the FIRST and ONLY drug FDA-approved for the control of pyrexia (fever) in horses.
*When administered according to label directions.
**Equine clinical relevance has not been determined.
Zimeta should not be used more frequently than every 12 hours. Do not use in horses with a hypersensitivity to dipyrone. See below for additional important safety information.
Sign up to receive future communications about Zimeta.
For more information or to place an order now:
Contact your preferred animal health distributor, your KindredBio Sales Specialist, or call KindredBio Customer Care at 1-888-608-2542.
Zimeta is indicated for the control of pyrexia in horses.
Important Safety Information
Zimeta™ (dipyrone injection) should not be used more frequently than every 12 hours. For use in horses only. Do not use in horses with a hypersensitivity to dipyrone, horses intended for human consumption or any food producing animals, including lactating dairy animals. Not for use in humans, avoid contact with skin and keep out of reach of children. Take care to avoid accidental self-injection and use routine precautions when handling and using loaded syringes. Prior to use, horses should undergo a thorough history and physical examination. Monitor for clinical signs of coagulopathy and use caution in horses at risk for hemorrhage. Concomitant use with other NSAIDs, corticosteroids and nephrotoxic drugs, should be avoided. As a class, NSAIDs may be associated with gastrointestinal, renal, and hepatic toxicity. The most common adverse reactions observed during clinical trials were Elevated Serum Sorbitol Dehydrogenase (SDH), Hypoalbuminemia and Gastric Ulcers. For product label, including complete safety information, click here.
References:
Zimeta™ is a trademark of Kindred Biosciences, Inc. in the United States and/or other countries.
US-ZIM-1900003A NOV-19